OREGON PUBLIC EMPLOYEES RETIREMENT FUND - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 126 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
OREGON PUBLIC EMPLOYEES RETIREMENT FUND ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$97,933
-3.2%
3,452
-0.3%
0.00%0.0%
Q4 2022$101,194
+4.3%
3,462
-5.8%
0.00%0.0%
Q3 2022$97,000
-43.3%
3,675
-4.3%
0.00%
-66.7%
Q2 2022$171,000
-20.5%
3,842
-11.5%
0.00%
+50.0%
Q1 2022$215,000
-4.9%
4,342
-2.3%
0.00%0.0%
Q4 2021$226,000
-16.9%
4,442
-9.0%
0.00%
-33.3%
Q3 2021$272,000
+30.1%
4,8830.0%0.00%
+50.0%
Q2 2021$209,000
+2.5%
4,8830.0%0.00%0.0%
Q1 2021$204,000
-8.5%
4,883
+2.1%
0.00%
-33.3%
Q4 2020$223,000
+29.7%
4,783
+17.8%
0.00%0.0%
Q3 2020$172,000
-11.8%
4,0590.0%0.00%0.0%
Q2 2020$195,000
+4.3%
4,0590.0%0.00%0.0%
Q1 2020$187,000
-23.4%
4,0590.0%0.00%0.0%
Q4 2019$244,000
+1.2%
4,059
-4.7%
0.00%0.0%
Q3 2019$241,000
+3.9%
4,259
+2.4%
0.00%0.0%
Q2 2019$232,000
+7.9%
4,159
-2.3%
0.00%0.0%
Q1 2019$215,000
+28.0%
4,259
+1.8%
0.00%0.0%
Q4 2018$168,0004,1820.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
JW Asset Management, LLC 475,755$25,068,00024.71%
Hudson Executive Capital LP 971,000$51,162,00015.09%
Park West Asset Management LLC 1,051,274$55,392,0002.47%
U S GLOBAL INVESTORS INC 19,200$1,012,0000.62%
Capital Impact Advisors, LLC 26,317$1,387,0000.57%
CLARK ESTATES INC/NY 56,278$2,965,0000.47%
IRIDIAN ASSET MANAGEMENT LLC/CT 873,131$46,005,0000.41%
ProQuest Associates IV LLC 6,777$357,0000.41%
Granite Investment Partners, LLC 114,207$6,017,0000.40%
GLOBEFLEX CAPITAL L P 30,900$1,628,0000.34%
View complete list of EAGLE PHARMACEUTICALS INC shareholders